Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Vaccines Market to reach USD 76.67 billion by 2028.

Global Vaccines Market Size study, By Type (Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines), By Technology (Monovalent vaccines, Multivalent vaccines), By Disease Indication (Pneumococcal disease, DTP, Influenza, HPV, Meningococcal disease, Polio, Rotavirus, Hepatitis, MMR, Varicella, Herpes zoster, Other disease indications), By Route of Administration (Intramuscular and subcutaneous administration, Oral administration, Other routes of administration), By Patient Type (Pediatric patients, Adult patients), and Regional Forecasts 2022-2028

Product Code: HLSDT-60751192
Publish Date: 22-04-2022
Page: 200

Global Vaccines Market is valued at approximately USD 47.74 billion in 2021and is anticipated to grow with a healthy growth rate of more than 7.0% over the forecast period 2022-2028. A vaccine is a biological product that offers vigorous acquired immunity to a specific infectious disease. A vaccine is used to boost the creation of antibodies and deliver immunity against one or several diseases. It comprises an agent that mimics a disease-causing microorganism and is usually produced from a debilitated or killed form of the microbe, its toxins, or one of its surface proteins. The growing occurrence of emerging and re-emerging infectious diseases, rising focus on immunization programs, increasing government support for vaccine development, and rising industry initiatives to augment vaccine R&D activities are the chief factors that may surge the market demand across the globe. For instance, as per the UNICEF, in November 2019, about 260,000 vaccination doses were delivered to prevent measles in Tonga, Samoa, and Fiji. However, the high cost of vaccine development impedes the growth of the market over the forecast period of 2022-2028. Also, the rising inclination on therapeutic vaccines is anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the global Vaccines market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to growing investments by the various non-government and government organizations for vaccine development and the high prevalence of infectious diseases. Whereas, Asia-Pacific is also anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as rising government initiatives, growing healthcare expenditure, and the presence of a large patient population would create lucrative growth prospects for the Vaccines market across the Asia-Pacific region.

Major market players included in this report are:
GlaxoSmithKline plc
Pfizer, Inc.
Sanofi Pasteur
Merck & Co., Inc.
CSL Limited
Emergent BioSolutions, Inc.
Johnson & Johnson
Serum Institute of India Pvt. Ltd.
Mitsubishi Tanabe Pharma Corporation
Panacea Biotec

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Conjugate vaccines
Inactivated and subunit vaccines
Live attenuated vaccines
Recombinant vaccines
Toxoid vaccines
By Technology:
Monovalent vaccines
Multivalent vaccines
By Disease Indication:
Pneumococcal disease
DTP
Influenza
HPV
Meningococcal disease
Polio
Rotavirus
Hepatitis
MMR
Varicella
Herpes zoster
Other disease indications
By Route of Administration:
Intramuscular and subcutaneous administration
Oral administration
Other routes of administration
By Patient Type:
Pediatric patients
Adult patients
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Vaccines Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion)
1.2.1. Vaccines Market, by Region, 2020-2028(USD Billion)
1.2.2. Vaccines Market, by Type, 2020-2028(USD Billion)
1.2.3. Vaccines Market, by Technology, 2020-2028(USD Billion)
1.2.4. Vaccines Market, by Disease Indication, 2020-2028(USD Billion)
1.2.5. Vaccines Market, by Route of Administration, 2020-2028(USD Billion)
1.2.6. Vaccines Market, by Patient Type, 2020-2028(USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Vaccines Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Vaccines Market Dynamics
3.1. Vaccines Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of emerging and re-emerging infectious diseases
3.1.1.2. Increasing government support for vaccine development
3.1.2. Market Challenges
3.1.2.1. High cost of vaccine development
3.1.3. Market Opportunities
3.1.3.1. Rising inclination on therapeutic vaccines
Chapter 4. Global Vaccines Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Vaccines Market, by Type
6.1. Market Snapshot
6.2. Global Vaccines Market by Type, Performance – Potential Analysis
6.3. Global Vaccines Market Estimates & Forecasts by Type, 2019-2028 (USD Billion)
6.4. Vaccines Market, Sub Segment Analysis
6.4.1. Conjugate Vaccines
6.4.2. Inactivated and Subunit Vaccines
6.4.3. Live Attenuated Vaccines
6.4.4. Recombinant Vaccines
6.4.5. Toxoid Vaccines

Chapter 7. Global Vaccines Market, by Technology
7.1. Market Snapshot
7.2. Global Vaccines Market by Technology, Performance – Potential Analysis
7.3. Global Vaccines Market Estimates & Forecasts by Technology, 2019-2028 (USD Billion)
7.4. Vaccines Market, Sub Segment Analysis
7.4.1. Monovalent vaccines
7.4.2. Multivalent vaccines
Chapter 8. Global Vaccines Market, by Disease Indication
8.1. Market Snapshot
8.2. Global Vaccines Market by Disease Indication, Performance – Potential Analysis
8.3. Global Vaccines Market Estimates & Forecasts by Disease Indication, 2019-2028 (USD Billion)
8.4. Vaccines Market, Sub Segment Analysis
8.4.1. Pneumococcal disease
8.4.2. DTP
8.4.3. Influenza
8.4.4. HPV
8.4.5. Meningococcal disease
8.4.6. Polio
8.4.7. Rotavirus
8.4.8. Hepatitis
8.4.9. MMR
8.4.10. Varicella
8.4.11. Herpes zoster
8.4.12. Other disease indications
Chapter 9. Global Vaccines Market, by Route of Administration
9.1. Market Snapshot
9.2. Global Vaccines Market by Route of Administration, Performance – Potential Analysis
9.3. Global Vaccines Market Estimates & Forecasts by Route of Administration, 2019-2028 (USD Billion)
9.4. Vaccines Market, Sub Segment Analysis
9.4.1. Intramuscular and subcutaneous administration
9.4.2. Oral administration
9.4.3. Other routes of administration
Chapter 10. Global Vaccines Market, by Patient Type
10.1. Market Snapshot
10.2. Global Vaccines Market by Patient Type, Performance – Potential Analysis
10.3. Global Vaccines Market Estimates & Forecasts by Patient Type, 2019-2028 (USD Billion)
10.4. Vaccines Market, Sub Segment Analysis
10.4.1. Pediatric patients
10.4.2. Adult patients
Chapter 11. Global Vaccines Market, Regional Analysis
11.1. Vaccines Market, Regional Market Snapshot
11.2. North America Vaccines Market
11.2.1. U.S. Vaccines Market
11.2.1.1. Type breakdown estimates & forecasts, 2019-2028
11.2.1.2. Technology breakdown estimates & forecasts, 2019-2028
11.2.1.3. Disease Indication breakdown estimates & forecasts, 2019-2028
11.2.1.4. Route of Administration breakdown estimates & forecasts, 2019-2028
11.2.1.5. Patient Type breakdown estimates & forecasts, 2019-2028
11.2.2. Canada Vaccines Market
11.3. Europe Vaccines Market Snapshot
11.3.1. U.K. Vaccines Market
11.3.2. Germany Vaccines Market
11.3.3. France Vaccines Market
11.3.4. Spain Vaccines Market
11.3.5. Italy Vaccines Market
11.3.6. Rest of Europe Vaccines Market
11.4. Asia-Pacific Vaccines Market Snapshot
11.4.1. China Vaccines Market
11.4.2. India Vaccines Market
11.4.3. Japan Vaccines Market
11.4.4. Australia Vaccines Market
11.4.5. South Korea Vaccines Market
11.4.6. Rest of Asia Pacific Vaccines Market
11.5. Latin America Vaccines Market Snapshot
11.5.1. Brazil Vaccines Market
11.5.2. Mexico Vaccines Market
11.6. Rest of The World Vaccines Market
Chapter 12. Competitive Intelligence
12.1. Top Market Strategies
12.2. Company Profiles
12.2.1. GlaxoSmithKline plc
12.2.1.1. Key Information
12.2.1.2. Overview
12.2.1.3. Financial (Subject to Data Availability)
12.2.1.4. Type Summary
12.2.1.5. Recent Developments
12.2.2. Pfizer, Inc.
12.2.3. Sanofi Pasteur
12.2.4. Merck & Co., Inc.
12.2.5. CSL Limited
12.2.6. Emergent BioSolutions, Inc.
12.2.7. Johnson & Johnson
12.2.8. Serum Institute of India Pvt. Ltd.
12.2.9. Mitsubishi Tanabe Pharma Corporation
12.2.10. Panacea Biotec
Chapter 13. Research Process
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now